跳至主要内容
临床试验/NCT00977704
NCT00977704已完成4 期

An Open-label Study of the Safety of Restylane and Perlane in the Correction of Peri-oral Wrinkles.

Medicis Global Service Corporation3 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2009年9月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
20
试验地点
3
主要终点
Local and Systemic Adverse Events

研究概览

简要总结

This is an open-label study to assess safety using Restylane and Perlane in the correction of facial wrinkles.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Same Wrinkle Severity (either both Moderate [3] or both Severe [4]) of marionette lines and upper peri-oral rhytids

排除标准

  • Active or chronic skin disease, inflammation or related conditions, near or on the Nasolabial Folds
  • Subjects who had undergone procedures based on active dermal response (e.g., laser or chemical peeling procedures) within 6 months prior to study entry
  • Use of any facial tissue augmenting therapy with non-permanent filler or aesthetic facial surgical therapy within 9 months prior to study entry
  • Permanent implant placed in the Nasolabial Fold area

结局指标

主要结局

Local and Systemic Adverse Events

时间窗: 2-weeks

To examine the safety of Restylane and Perlane when used in the treatment of facial wrinkles and folds by identification of the point incidence of: * All local adverse events as reported by healthcare professional * All systemic adverse events (related and unrelated)

次要结局

未报告次要终点

研究者

发起方
Medicis Global Service Corporation
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验

Study of Restylane and Perlane in the Correction of... | 临床试验